Active Research Trials

• 1.Hidradenitis Supperativa Research Study for Teens and Adults (28 Months)

• 2.Adult Eczema Clinical Trial (9 Months)

• 3.Subcutaneous Abdominal Fat Research Study (25 Weeks)

• 4.Clinical Trial for Atopic Dermatitis (13-17 Months)

• 5.Research Trial for Cutaneous Lupus Erythematosus (80 Weeks)

• 6.Clinical Trial for Prurigo Nodularis Enhancement (15-16 Months)

• 7.Child-Adolescent Atopic Dermatitis Research Trial (28 Weeks)

• 8.Clinical Trial for Chronic Hand Eczema (18 Months)

• 9.Clinical Trial for Moderate-to-Severe Atopic Dermatitis (Part 1)

• 10.Hidradenitis Suppurativa Clinical Trial for Adults (63 Weeks)

• 11.Stroke Prevention – Clinical Trial for Adults (10-34 Months)

• 12.Alopecia Areata – Patchy Baldness Clinical Trial (33 Months)

• 13.Open-Label Clinical Trial for Atopic Dermatitis (180 Weeks)

• 14.Clinical Trial for Patients at High Cardiovascular Risk (3-5 Years)

• 15.Investigational Atopic Dermatitis Study (12 Weeks)

• 16.Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis

• 17.Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

• 18.Atopic Dermatitis Research Trial (Approximately 41 Weeks)

• 19.Discoid Lupus Erythematosus – Research Trial (60 Weeks)

• 20.Research Trial for Adults with Eczema (32 Weeks)

• 21.Clinical Trial for Enlarged Pores and Excessive Sebum Production (12 Weeks)

• 22.Clinical Trial for Heart Failure and Inflammation (4 Years)

• 23.Hidradenitis Suppurativa Clinical Research Trial (40 Weeks)

• 24.Clinical Trial for Prurigo Nodularis (PN) – 56 Weeks

• 25.Clinical Trial for Plaque Psoriasis (20 Weeks)

• 26.Investigational Treatment for Alopecia Areata – Clinical Trial (17 Weeks)

• 27.Non Segmental Vitiligo Research Trial (60 Weeks)

• 28.Clinical Trial for Adults with Plaque Psoriasis (60 Weeks)

• 29.Phase 3 Research Trial for Atopic Dermatitis – Eczema 5 (68 Weeks)

• 30.Phase 3 Research Trial for Atopic Dermatitis – Eczema 4 (68 Weeks)

• 31.Atopic Dermatitis – Research Trial (12 Weeks)

• 32.Atopic Dermatitis – Research Trial (41 Weeks)

• 33.Phase 3 Research Trial for Atopic Dermatitis – Eczema 2 (40 Weeks)

• 34.Plaque Psoriasis Clinical Trial – Moderate-to-Severe (4 Months)

• 35.Phase 3 Research Trial for Atopic Dermatitis – Eczema 1 (40 Weeks)

• 36.Phase 3 Research Trial for Atopic Dermatitis – Eczema 3 (40 Weeks)

• 37.Atopic Dermatitis – Research Trial (10 Weeks)

• 38.Child Chronic Urticaria (Hives) Research Trial (40 Weeks)

• 39.Atopic Dermatitis – Research Trial (52 Weeks)

• 40.Clinical Trial for Adults with Eczema (20 Weeks)

• 41.Active Atopic Dermatitis Research Trial (29 Weeks)

• 42.Research Trial for Congenital Ichthyosis (26-38 Weeks)

• 43.Chronic Hand Eczema – Research Trial (18 Weeks)

• 44.Distal Subungual Onychomycosis Research Trial (60 Weeks)

• 45.Atopic Dermatitis – Eczema Clinical Trial (4 Months)

• 46.Psoriatic Arthritis Research Trial 1 (68 Weeks)

• 47.Research Trial for Psoriatic Arthritis (60 Weeks)

• 48.Psoriatic Arthritis Research Trial (60 Weeks)

• 49.Research Trial for Pediatric Plaque Psoriasis

• 50.Plaque Psoriasis Trial for Teens (66 Weeks)

• 51.Pediatric Research Trial for Plaque Psoriasis (17-57 Weeks)

• 52.Nail and Body Psoriasis Research Trial (76 Weeks)

• 53.Research Trial for Cutaneous Lupus Erythematosus (60 Weeks)

• 54.Research Trial for Chronic Hives – Part C (40 Weeks)

• 55.Chronic Heart Failure Research Trial (25 Months)

• 56.Asthma Research Trial Testing Inhaler (30-58 Weeks)

• 57.Research Trial for Acute Myocardial Infarction (about 30 Months)